High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients
Objective: B-cell-activating factor (BAFF) has been determined to be involved in HIV-1 infection and is correlated with disease progression, while its homologous molecule, a proliferation-inducing ligand (APRIL), is less frequently reported, and its role remains unclear. We aimed to characterize the...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00299/full |
id |
doaj-7f1aa85aa33a45b290eebb6b1a8ceb29 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yubin Liu Xiuxia Li Yang Han Zhifeng Qiu Xiaojing Song Bingxiang Li Bingxiang Li Han Zhang Han Zhang Hongye Wang Hongye Wang Kai Feng Kai Feng Longding Liu Longding Liu Jingjing Wang Jingjing Wang Ming Sun Ming Sun Taisheng Li Taisheng Li Taisheng Li |
spellingShingle |
Yubin Liu Xiuxia Li Yang Han Zhifeng Qiu Xiaojing Song Bingxiang Li Bingxiang Li Han Zhang Han Zhang Hongye Wang Hongye Wang Kai Feng Kai Feng Longding Liu Longding Liu Jingjing Wang Jingjing Wang Ming Sun Ming Sun Taisheng Li Taisheng Li Taisheng Li High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients Frontiers in Medicine APRIL BAFF HIV-1 disease progression antibody response immune activation functional cells |
author_facet |
Yubin Liu Xiuxia Li Yang Han Zhifeng Qiu Xiaojing Song Bingxiang Li Bingxiang Li Han Zhang Han Zhang Hongye Wang Hongye Wang Kai Feng Kai Feng Longding Liu Longding Liu Jingjing Wang Jingjing Wang Ming Sun Ming Sun Taisheng Li Taisheng Li Taisheng Li |
author_sort |
Yubin Liu |
title |
High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients |
title_short |
High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients |
title_full |
High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients |
title_fullStr |
High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients |
title_full_unstemmed |
High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients |
title_sort |
high april levels are associated with slow disease progression and low immune activation in chronic hiv-1-infected patients |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2020-07-01 |
description |
Objective: B-cell-activating factor (BAFF) has been determined to be involved in HIV-1 infection and is correlated with disease progression, while its homologous molecule, a proliferation-inducing ligand (APRIL), is less frequently reported, and its role remains unclear. We aimed to characterize the APRIL levels in subjects with different HIV-1 infection statuses and determine the relationships with disease progression and immune activation.Methods: The plasma levels of APRIL were compared among 17 long-term non-progressors (LTNPs), 17 typical progressors (TPs), 10 ART-treated patients, and 10 healthy donors (HDs). Seventeen LTNPs and a subset of TPs (n = 6) who initiated ART were assessed longitudinally. The correlations between the APRIL levels and markers of disease progression, B-cell count and specific antibody response, and markers of immune activation and functional cells were analyzed.Results: The circulating APRIL levels were significantly elevated in the LTNPs relative to the TPs, ART-treated patients, and HDs. The longitudinal investigation revealed that the APRIL levels were decreased during follow-up in the LTNPs. ART did not significantly influence the APRIL levels. The levels of plasma APRIL were negatively correlated with the plasma HIV-1 viral load and cellular HIV-1 DNA levels and positively correlated with the CD4+ T-cell count and CD4/CD8 ratio. An inverse correlation was observed between the APRIL and BAFF levels. Furthermore, the APRIL levels were negatively correlated with the frequency of activated CD8+ T cells and levels of interferon gamma-induced protein 10 (IP-10) and monocyte chemoattractant protein-1 (MCP-1). Finally, positive correlations were observed among the APRIL levels, the frequency of CD8+CD28+ T cells, and natural killer (NK) cell count.Conclusion: The APRIL levels were elevated in the LTNPs and negatively correlated with disease progression and immune activation, suggesting likely protective activity in HIV-1 infection. |
topic |
APRIL BAFF HIV-1 disease progression antibody response immune activation functional cells |
url |
https://www.frontiersin.org/article/10.3389/fmed.2020.00299/full |
work_keys_str_mv |
AT yubinliu highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT xiuxiali highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT yanghan highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT zhifengqiu highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT xiaojingsong highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT bingxiangli highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT bingxiangli highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT hanzhang highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT hanzhang highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT hongyewang highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT hongyewang highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT kaifeng highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT kaifeng highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT longdingliu highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT longdingliu highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT jingjingwang highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT jingjingwang highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT mingsun highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT mingsun highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT taishengli highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT taishengli highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients AT taishengli highaprillevelsareassociatedwithslowdiseaseprogressionandlowimmuneactivationinchronichiv1infectedpatients |
_version_ |
1724663782550011904 |
spelling |
doaj-7f1aa85aa33a45b290eebb6b1a8ceb292020-11-25T03:09:14ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-07-01710.3389/fmed.2020.00299513139High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected PatientsYubin Liu0Xiuxia Li1Yang Han2Zhifeng Qiu3Xiaojing Song4Bingxiang Li5Bingxiang Li6Han Zhang7Han Zhang8Hongye Wang9Hongye Wang10Kai Feng11Kai Feng12Longding Liu13Longding Liu14Jingjing Wang15Jingjing Wang16Ming Sun17Ming Sun18Taisheng Li19Taisheng Li20Taisheng Li21Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaInstitute of Medical Biology, Peking Union Medical College and Chinese Academy of Medical Sciences, Kunming, ChinaYunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming, ChinaInstitute of Medical Biology, Peking Union Medical College and Chinese Academy of Medical Sciences, Kunming, ChinaYunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming, ChinaInstitute of Medical Biology, Peking Union Medical College and Chinese Academy of Medical Sciences, Kunming, ChinaYunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming, ChinaInstitute of Medical Biology, Peking Union Medical College and Chinese Academy of Medical Sciences, Kunming, ChinaYunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming, ChinaInstitute of Medical Biology, Peking Union Medical College and Chinese Academy of Medical Sciences, Kunming, ChinaYunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming, ChinaInstitute of Medical Biology, Peking Union Medical College and Chinese Academy of Medical Sciences, Kunming, ChinaYunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming, ChinaInstitute of Medical Biology, Peking Union Medical College and Chinese Academy of Medical Sciences, Kunming, ChinaYunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming, ChinaDepartment of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaClinical Immunology Center, Chinese Academy of Medical Sciences, Beijing, ChinaSchool of Medicine, Tsinghua University, Beijing, ChinaObjective: B-cell-activating factor (BAFF) has been determined to be involved in HIV-1 infection and is correlated with disease progression, while its homologous molecule, a proliferation-inducing ligand (APRIL), is less frequently reported, and its role remains unclear. We aimed to characterize the APRIL levels in subjects with different HIV-1 infection statuses and determine the relationships with disease progression and immune activation.Methods: The plasma levels of APRIL were compared among 17 long-term non-progressors (LTNPs), 17 typical progressors (TPs), 10 ART-treated patients, and 10 healthy donors (HDs). Seventeen LTNPs and a subset of TPs (n = 6) who initiated ART were assessed longitudinally. The correlations between the APRIL levels and markers of disease progression, B-cell count and specific antibody response, and markers of immune activation and functional cells were analyzed.Results: The circulating APRIL levels were significantly elevated in the LTNPs relative to the TPs, ART-treated patients, and HDs. The longitudinal investigation revealed that the APRIL levels were decreased during follow-up in the LTNPs. ART did not significantly influence the APRIL levels. The levels of plasma APRIL were negatively correlated with the plasma HIV-1 viral load and cellular HIV-1 DNA levels and positively correlated with the CD4+ T-cell count and CD4/CD8 ratio. An inverse correlation was observed between the APRIL and BAFF levels. Furthermore, the APRIL levels were negatively correlated with the frequency of activated CD8+ T cells and levels of interferon gamma-induced protein 10 (IP-10) and monocyte chemoattractant protein-1 (MCP-1). Finally, positive correlations were observed among the APRIL levels, the frequency of CD8+CD28+ T cells, and natural killer (NK) cell count.Conclusion: The APRIL levels were elevated in the LTNPs and negatively correlated with disease progression and immune activation, suggesting likely protective activity in HIV-1 infection.https://www.frontiersin.org/article/10.3389/fmed.2020.00299/fullAPRILBAFFHIV-1 disease progressionantibody responseimmune activationfunctional cells |